Quironsalud Madrid
| トルコ | オーストリア | スペイン | |
| 陽子線治療 | から $70,000 | から $80,000 | から $25,535 |
| 陽子線治療 | から $30,000 | から $80,000 | から $70,000 |
| 小線源治療 | から $3,465 | から $15,000 | から $10,000 |
| 乳癌化学療法 | から $1,200 | から $15,000 | から $3,500 |
| 乳がんに対する陽子線治療 | から $30,000 | から $55,000 | から $85,000 |
12,000件以上の腹腔鏡手術を実施 – バジェスタ・ロペス医師は、セントロ・メディコ・テクノンにおいて低侵襲技術の先駆者として活躍してきました。
Dr. Enrique Grande, MD, PhD, MSc, is a medical oncologist with more than 20 years of experience. He is an international expert in genitourinary and neuroendocrine tumors. He directs the Medical Oncology Department and the One Oncology Madrid Cancer Program at QuirónSalud, Spain’s largest private healthcare network. He leads an integrated, multidisciplinary model with access to targeted therapies and clinical trials.
He is a pioneer in precision oncology. He uses molecular profiling and biomarker-based care. He has authored more than 300 peer-reviewed papers. He serves as a principal investigator and sits on steering committees for many international trials. These studies help set standards of care in urothelial bladder and neuroendocrine tumors. He contributes to guidelines and programs at ESMO, ASCO, ENETS, and EAU.